Key facts
- Dyneval’s last known valuation is $5.7M (Jan 2025).
- It has raised $3.1M; the latest was Accelerator/Incubator in Mar 2025.
- Notable investors include Innovate UK, Scottish Enterprise, Cottagequinn Enterprises, Gabriel Investment Syndicate, Global Agri-Food Advancement Partnership — 12 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 12 names
- ·Watchlist + deal alerts for Dyneval
- ·The full record, as it builds
Funding rounds
No funding rounds for Dyneval are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Dyneval
Developer of a measurement technology platform designed to analyze dynamics at the nano- and micro-scale. The company offers portable equipment that accurately characterizes particles and microorganisms, enabling health and biotech sectors to move beyond visual assessments toward more accurate, reliable analysis.
- Sector
- Healthcare
- HQ
- Edinburgh, United Kingdom
- Founded
- 2020
- Employees
- 14
- Website
- dyneval.com/
- Ownership
- Privately Held (backing)
Dyneval doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Dyneval shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Dyneval in its N-PORT filings yet. We sweep new filings monthly.